Technology·Aug 22, 2026
Japan Launches First Oncolytic Virus Therapy for Esophageal Cancer
Oncolys BioPharma's genetically modified virus treatment marks a new frontier in cancer therapeutics across Asia
By Aiko Nakamura · 3 min ·
Every BriefAsia story tagged Pharmaceuticals, newest first.

Oncolys BioPharma's genetically modified virus treatment marks a new frontier in cancer therapeutics across Asia

Nabota now operates across seven Middle Eastern markets, marking the widest footprint among South Korean toxin brands in the region

HLB Pep's Drug Master File registration marks a strategic step in the company's bid to supply critical-care ingredients to American pharmaceutical manufacturers